Month: April 2021

New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, or at high risk for SARS-CoV-2 infection, could move the needle on clinician acceptance of the treatments, experts say. Two monoclonal antibody formulations, Eli Lilly’s bamlanivimab and Regeneron’s cocktail of two antibodies, casirivimab and imdevimab, received emergency use authorizations from […] Read More

The day has finally come. You’ve received the second dose of a Covid-19 vaccine currently on the Western market — Moderna, Pfizer-BioNTech or Oxford-AstraZeneca. Does that mean you’re free to go about life as you did before the pandemic once immunity kicks in? Sorry, there is no immunity passport yet, experts told CNN. There are […] Read More

With the COVID-19 vaccination programme being rolled out across the country Dr Sheeba Irshad, senior clinical lecturer, breast cancer medical oncologist and clinical deputy head of the Breast Cancer Now Research Unit at Kings College London, answers some common questions about the current vaccines and if they are safe and effective for people with breast […] Read More

We all want this pandemic to end. By February 2021, the COVID-19 pandemic caused 100 million confirmed infections and 2.2 million deaths worldwide. In the United States, 26 million people have been infected with COVID-19 and nearly 500,000 people have died. This winter, 3,300 U.S. lives were lost every day to a surge of COVID-19 […] Read More

After more than two decades, women between ages 20 and 39 are seeing a slight increase in the rates of breast cancer mortality. The two decade-plus trend of declining death rates from breast cancer is at an end for women under age 40, prompting experts to call for greater awareness of and more research into […] Read More